Articles tagged with Adaptive Immune Response
Researchers found that a daily spermidine supplement improved immune response to COVID-19 vaccination in older adults. Spermidine reduced markers of immunosenescence and stimulated autophagy, leading to higher antibody levels and better neutralizing activity against multiple viral variants.
Scientists at La Jolla Institute for Immunology have discovered that 'cross-reactive' T cells can recognize multiple species of paramyxovirus, including measles and Nipah viruses. This broad protection is essential in combating emerging diseases with unknown viral strains.
Researchers at La Jolla Institute for Immunology have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine. This approach may protect against life-threatening infections from Lassa virus, Junin virus, and many other arenaviruses.
A new blood-based biomarker has been discovered to help identify individuals at higher risk of developing cancer in people with Lynch Syndrome. The biomarker uses immune signatures detected in blood samples to provide unique characteristics that can detect cancer risk, allowing for early detection and personalized surveillance.
Researchers at MD Anderson have made significant discoveries in the treatment of rare bile duct cancers, with zanidatamab showing promising results. Additionally, a study identified RASH3D19 as a target to overcome treatment resistance in KRAS-mutant cancers.
Researchers have made breakthroughs in overcoming immune reactions behind human rejection of transplanted pig kidneys, paving the way for more successful clinical trials. The study reveals three major immune responses against the pig kidney and identifies potential biomarkers as early-warning systems for rejection.
Researchers at La Jolla Institute for Immunology discovered that ALS is likely caused by an autoimmune reaction triggered by inflammatory CD4+ T cells targeting specific proteins in the nervous system. Anti-inflammatory CD4+ T cells may slow disease progression and prolong survival times.
Researchers at Penn State College of Medicine discovered a new function of antibody-making B cells in response to flu infection. These cells produce a key signaling molecule called interleukin-1 beta, which is necessary for developing a robust immune response and forming optimal germinal centers.
Researchers discovered a multi-faceted mechanism behind ASD, revealing the gut microbiota and host immune system's influence on disease progression. Precision-selected probiotics restored metabolic balance, reduced neuroinflammation, and ameliorated behavioral abnormalities in ASD mouse models.
Researchers found that mice receiving both doses of COVID-19 vaccine in the same limb had a faster initial antibody response. Long-term immunity was similar between vaccination approaches.
A USC Stem Cell mouse study identifies a small subset of blood stem cells as the primary driver of immune aging. The researchers found that this subset overproduces innate immune cells, leading to an age-associated imbalance and increased disease risk. By targeting this subset, the study suggests a potential therapy to delay immune agi...
A novel strategy using venetoclax and azacitidine demonstrates significant anti-cancer effect with mild toxicity for relapsed/refractory AML patients. The treatment showed markedly better survival rates after one year compared to a control group, with improved 'graft-versus-leukemia effects' via alterations of immune cells.
Researchers from Osaka University found that Csk inhibits germinal center B cell signaling, decreasing reactive oxygen species production and promoting affinity maturation. This study reveals the crucial role of Csk tyrosine kinase in regulating B cell development.
Therapeutic phages can detect epithelial cells of the human respiratory tract, eliciting proinflammatory responses. Specific phage properties and airway microenvironment influence these responses.
Researchers found that vaccinated B cell-deficient individuals have a robust T cell response to SARS-CoV-2, despite lack of anti-spike antibodies, resulting in markedly reduced rates of hospitalization and severe COVID-19. This study provides reassuring evidence for immunocompromised patients to get vaccinated.
Researchers have discovered that immune cells play a crucial role in directing the growth of human lung tissue during development, revolutionizing our understanding of early lung development. The findings also suggest that early immune disturbances could manifest as pediatric lung disease.
A study by researchers at the Medical University of Vienna found that natural killer cells may play a crucial role in protecting against multiple sclerosis (MS) disease. The investigation revealed that strong EBV-specific and autoreactive immune responses combined with poor autoimmunity control increase MS risk.
Researchers at Institute for Systems Biology have made a breakthrough discovery about T cells, finding that the genetically encoded T-cell receptor sequence determines a T cell's function. This fundamental discovery has huge potential for developing custom immune responses to specific antigens.
Researchers used dynamic total-body PET scans to visualize immune T cell distribution in recovering patients. The study found increased concentrations of CD8+ T cells in the bone marrow of recovering COVID patients compared to healthy controls.
Researchers at Karolinska Institutet have found that weightlessness affects T cells in astronauts' immune systems, making them less effective at fighting infections. The study's results could lead to new treatments for reversing these changes.
Researchers found that CD4+ T cells initiate fat wasting, while CD8+ T cells induce muscle wasting, which surprisingly helps the mice fight infection and survive. The study sheds light on the complex relationship between immune cells and wasting responses.
Researchers at IOCB Prague have determined the first cryo-EM structures of a surface receptor of Trypanosoma brucei gambiense in complex with human complement factor C3. This discovery sheds light on how the parasite avoids clearance from the human bloodstream and survives within the immune system.
Researchers from Nara Institute of Science and Technology found that alveolar macrophages act as antigen-presenting cells to prime CD8+ T cell expansion in the lungs. This process involves the production of interleukin 18, leading to the development of resident memory-type cell populations.
A recent international study has shed light on the inner workings of the adaptive immune response, revealing how killer T cells recognize viral invaders using molecular road signs. The study highlights the crucial role of chaperones in ensuring the stability and longevity of these road signs, allowing for more effective detection and d...
A research team at the University of Oklahoma has developed a new approach to triggering an adaptive immune response. The study presents a method to create molecules that can integrate into cells, cause stress on their membrane, and release signals that recruit immune cells to their location.
Researchers discovered cancer cells produce a unique collagen that alters the tumor microbiome and promotes cancer progression. Loss of this collagen reduces cancer cell proliferation and boosts anti-tumor immune response, offering a potential therapeutic strategy.
A new study suggests that current vaccine boosters intensify protections against serious infection caused by Omicron subvariants. The research found that booster doses bring neutralizing antibodies to appreciable levels against all Omicron subvariants, consistent with other evidence of expanded memory B cells and antibody production.
A systematic review and meta-analysis found that physical activity can boost the body's immune response to influenza vaccination. The study analyzed data from over 100,000 individuals and concluded that regular exercise may provide better protection against the flu.
A new study found that patients with long COVID have virus-specific T cell levels over 100 times higher than those who recovered from the disease. The research team's findings suggest hidden viral reservoirs may be causing long-term symptoms, guiding future treatments towards vaccines and antiviral medications.
Researchers discovered that adaptive immune response against TB matures over time, with key players in immunity becoming activated by three months after infection. The emergence of these activated T cells is inversely correlated with the number of granuloma-contained live bacteria, suggesting they play critical roles in bacterial control.
Researchers discovered that memory B cells produce non-specific antibodies to combat virus mutants, working alongside phagocytes to screen for variants. This mechanism may offer protection against SARS-CoV2 and HIV variants, and could influence vaccine development.
A new study by Princeton University researchers reveals that macrophages, a type of immune cell, are crucial in the early immune response to SARS-CoV-2. The study used humanized mice with human lung tissue and blood stem cells to investigate the role of macrophages and identified specific genes associated with an effective antiviral re...
Researchers found that people who had COVID-19 and then got vaccinated generated an immune response more specific to fighting viral infections, producing a broader antibody response. This hybrid immunity also produced a cellular immune response called Th1 response, which is antiviral.
Researchers from the University of Copenhagen have discovered that naturally acquired immunity to malaria works differently than immunity following vaccination. The immune system uses natural killer cells to fight the parasite, which is more tailored to the disease than other typical infections.
A study found that elevated mucosal-associated invariant T (MAIT) cell activation is strongly correlated with poor immune coordination and increased mortality in severe COVID-19 patients. In contrast, focused immune responses driven by interferon-alpha are associated with survival.
A new study from La Jolla Institute for Immunology shows that the Moderna COVID-19 vaccine generates durable T cell memory and antibodies, even in people over 70. The researchers found strong CD4+ and CD8+ T cell responses to the vaccine, comparable to those seen in recovered COVID-19 patients.
A recent study explores the plant immune system using chimeric maize leaves with an auto-active R protein. Researchers found that Rp1-D21 triggers a defense response without recognition events, leading to cell death in affected areas but not neighboring cells.
A new research strategy enhances COVID-19 vaccine effectiveness by providing 'border protection' immunity in the nose, mouth and blood. The approach involves suppressing an enzyme that breaks down both pathogens and immune cells, resulting in a robust antibody response and improved protection against infections.
Researchers found that combining unmodified anti-tumor antibodies with MEKi and immune checkpoint blockade generated a robust adaptive anti-tumor response, sustained by immune checkpoint inhibition. This combination therapy showed improved therapeutic efficacy in mouse models of melanoma.
A new study published in Molecular Ecology reveals that the genes responsible for protecting frogs may actually be leading to their demise in the face of the invasive chytridiomycosis disease. Researchers found that frogs that died from the disease had higher expression of immune system genes than those that survived.
An analysis of COVID-19 patients identified unique immune signatures in severe cases. The study found characteristic immune phenotypes and innate immune system changes, suggesting targeted strategies for clinical care.
A new USC study proposes that a short regimen of immunosuppressant drugs applied early in the disease process may improve patient outcomes by delaying the adaptive immune response. This approach aims to prevent the interaction between the innate and adaptive immune responses, which can lead to a cytokine storm and tissue damage.
Researchers have identified a potential vaccine to prevent respiratory infections in humans by understanding how the human metapneumovirus (HMPV) hides from the immune system. A mutated form of HMPV was created, which triggers a stronger innate immune response, effectively preventing infection and promoting an adaptive immune response.
Walter and Eliza Hall Institute researchers have identified a molecular switch that impacts immune responses to viral infections, enabling T cells to distinguish between different viruses and controlling protective antibody production. This discovery could lead to more effective vaccines against previously hard-to-prevent viruses.
Researchers found that Ebola survivors exhibit memory immune responses, including specific T cells against the virus, persisting over 2 years after infection. These findings could help develop more effective vaccines by boosting key immune cells needed for long-lasting protective immunity.
A study found that specific bacteria from the mother's gut stimulate the baby's immune responses during vaginal birth, but this transmission is impacted in children born by caesarean section. This may explain why caesarean-born children are more prone to chronic diseases.
Research reveals that genetic factors and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. The study also found that older individuals and women exhibit stronger antibody responses against most antigens.
Researchers discovered that biophysical cues of pathogen-associated molecular patterns (PAMPs) influence the immune system's response to pathogens. The findings suggest that understanding these cues can help fine-tune vaccine responses and generate potent immune reactions.
A study published in Nature Communications found that nearly three quarters of immune traits are genetically determined, with adaptive responses being more influenced by genetics than previously thought. The research also highlights the importance of environmental factors such as diet on shaping innate immunity in adult life.
Research shows that aging alters antibody responses to oral bacteria, with significant positive correlations observed across the population. Specifically, antibody levels to Porphyromonas gingivalis and Treponema denticola increased with age, while those to Aggregatibacter actinomycetemcomitans did not.
Researchers at The Geisel School of Medicine discover that changes in metabolism, mediated by the HIF1α pathway, are critical for trained immunity. This finding has potential implications for preventing and treating inflammatory diseases and enhancing vaccine efficacy.
Researchers show that mice injected with small dose of bee venom developed immunity to lethal dose, surviving three times longer than control mice. Protection depends on IgE signaling and mast cell activation, suggesting a positive evolutionary pressure for this type of defense.
A team of researchers has discovered a previously unknown mechanism that prevents the immune system from going into overdrive, shedding light on autoimmune diseases, allergies and chronic inflammation. The discovery could lead to new therapeutics for disorders caused by faulty immune responses.
Researchers developed mathematical models to investigate viral control factors, revealing that innate immune responses, such as natural killer cells and interferon, explain the initial rapid decline and subsequent second peak of viral levels. Ultimately, the adaptive immune response is necessary for eventual viral clearance.
Dr. Akiko Iwasaki is recognized for her groundbreaking work on tissue-specific properties of dendritic cells and the critical role of autophagy in innate immune recognition of viruses. Her research has a fundamental impact on the fields of autophagy and antiviral immunity.
Scientists have discovered a gene that regulates the function of Natural Killer cells, which play a crucial role in the immune system's first line of defense. By blocking this receptor, they found that NK cells become more effective at combating microorganisms and tumor cells, opening up new therapeutic possibilities.
A study found that primate immune system differences explain why humans are more susceptible to certain viral infections, such as HIV and hepatitis B. Genomic comparisons revealed unique gene expression patterns in humans compared to chimpanzees and rhesus macaques.
A molecule that binds toll-like receptors doubles the early antibody response to an antigen and shifts it to a more effective IgG form. The findings support bridge immunity, which links innate and adaptive arms of the immune response.
Researchers at Duke University Medical Center discovered that the cytokine interleukin-17 plays a significant role in disc disease and may lead to the development of new therapeutic approaches. Targeting this immune response could reduce painful inflammation and halt the evolution of arthritis.
Natural killer cells help maintain a balance between T cells and the immune system, preventing over-response that can cause harm. Understanding how to keep NK cells around could lead to new treatments for patients with compromised immune systems.